REFERENCES
- Arakawa Y., Kawakami S., Yamashita F., Hashida M. Effect of low-molecular-weight beta-cyclodextrin polymer on release of drugs from mucoadhesive buccal film dosage forms. Biological & Pharmaceutical Bulletin 2005; 28(9)1679–83
- Artusi M., Santi P., Colombo P., Junginger H. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. International Journal of Pharmaceutics 2003; 250: 203–213
- Aungst B., Rogers N. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. International Journal of Pharmaceutics 1989; 53: 227–235
- Bredenberg S., Duberg M., Lennernäs B., Lennernäs H., Pettersson A., Westerberg M., Nyström C. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. European Journal of Pharmaceutical Sciences 2003; 20: 327–334
- Burgalassi S., Panichi L., Saettone M., Jacobsen J., Rassing M. Development and in vitro/in vivo testing of mucoadhesive buccal patches releasing benzydamine and lidocaine. International Journal of Pharmaceutics 1996; 133: 1–7
- Cui Z., Mumper R. Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharmaceutical Research 2002; 19(7)947–953
- Deneer V., Drese G., Roemele P., Verhoef J., Huen L., Kingma J., Brouwers J., Junginger H. Buccal transport of flecaininde and sotalol: effect of a bile salt and ionization state. International Journal of Pharmaceutics, 241: 127–134
- Dollo G., Estebe J., Corre P., Chevanne F., Ecoffey C., Verge R. Endotracheal tube cuffs filled with lidocaine as a drug delivery system: in vitro and in vivo investigations. European Journal of Pharmaceutical Sciences 2001; 13: 319–323
- Gandhi R., Robinson J. Mechanism of penetration enhancement for transbuccal delivery of salicylic acid. International Journal of Pharmaceutics 1992; 85: 129–140
- Ganem-Quintanar A., Quintanar-Guerrero D., Falson-Rieg F., Buri P. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. International Journal of Pharmaceutics 1998; 173: 203–210
- Guo J., Cooklock K. The effect of backing materials and multilayered systems on the characteristics of bioadhesive buccal patches. Journal of Pharmacy and Pharmacology 1996; 48: 255–257
- Hao J., Heng P. Buccal delivery systems. Drug Development and Industrial Pharmacy 2003; 29(8)821–832
- Heusler H. Quantitative analysis of common anaesthetic agents. Journal of Chromatography 1985; 340: 273–319
- Jay S., Fountain W., Cui Z., Mumper R. Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax film composite disks. Journal of Pharmaceutical Sciences 2002; 91(9)2016–2025
- Kabanov A., Batrakova E., Alakhov V. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of Controlled Release 2002; 82: 189–212
- Kabanov A., Batrakova E., Miller D. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Advanced Drug delivery Reviews 2003; 55: 151–164
- Kang L., Jun H., McCall J. HPLC assay of Lidocaine in plasma with solid phase extraction and UV detection. Journal of Pharmaceutical and Biomedical Analysis 1999; 19: 737–745
- Katzung B. Basic and Clinical Pharmacology, 7th. 1998, Chapter 14.
- Khanna R., Agarwal S., Ahuja A. Muco-adhesive buccal tablets of clotrimazole for oral candidiasis. Drug Development and Industrial Pharmacy 1997; 23(8)831–837
- Klein J., Fernandes D., Gazarian M., Kent G., Koren G. Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high performance liquid chromatography. Journal of Chromatography B 1994; 655: 83–88
- Lee J., Park J., Robinson J. Bioadhesive-based dosage forms; the next generation. Journal of Pharmaceutical Sciences 2000; 89(7)850–866
- Lopez C., Portero A., Jato J., Alonso M. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. Journal of Controlled Release 1998; 55: 143–152
- Neal C., Poklis A. Sensitive HPLC for simultaneous quantification of lidocaine and its metabolites monoethylglycinexylidide and glycinexylidide in serum. Clinical Chemistry 1996; 42(2)330–331
- Okamoto H., Nakamori T., Arakawa Y., Iida K., Danjo K. Development of polymer film dosage forms of lidocaine for buccal administration: II. Comparison of preparation methods. Journal of Pharmaceutical Sciences 2002; 91(11)2424–2432
- Peh K., Wong C. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. Journal of Pharmacy and Pharmaceutical Sciences 1999; 2(2)53–61
- Perioli L., Ambrogi V., Angelici A., Ricci M., Giovagnoli S., Capuccella M., Rossi C. Development of mucoadhesive patches for buccal administration of ibuprofen. Journal of Controlled Release 2004; 99(1)73–82
- Qvist M., Hoeck U., Kreilgaard B., Madsen F., Frokjaer S. Release of chemical permeation enhancers from drug-in-adhesive transdermal patches. International Journal of Pharmaceutics 2002; 231: 253–263
- Rathbone M. Oral Mucosal Drug Delivery. Marcel Dekker, Inc.: 270 Madison Avenue, New YorkUSA 1996
- Repka M., Gutta K., Prodduturi S., Munjal M., Stodghill S. Characterization of cellulosic hot-melt extruded films containing lidocaine. European Journal of Pharmaceutics and Biopharmaceutics 2005; 59(1)189–196
- Senel S., Kremer M., Kas S., Wertz P., Hincal A., Squier C. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 2000; 21: 2067–2071
- Shargel L., Yu A. Applied Biopharmaceutics and Pharmacokinetics, 3rd. Appleton and Lange: Norwalk, ConnecticutUSA 1993
- Shin S., Kim J., Oh I. Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide. Drug Development and Industrial Pharmacy 2000; 26(3)307–312
- Shojaei A. Buccal mucosa as a route for systemic drug delivery: a review. Journal of Pharmacy and Pharmaceutical Sciences 1998; 1(1)15–30
- Shojaei A., Chang R., Guo X., Burnside B., Couch R. Systemic drug delivery via the buccal mucosal route. Pharmaceutical Technology 2001; 6: 70–80
- Shojaei A., Zhou S., Li X. Transbuccal delivery of acyclovir (II): Feasibility, system design, and in vitro permeation studies. Journal of Pharmacy and Pharmaceutical Science, 1(2)66–73
- Singla A., Chawla M., Singh A. Potential applications of Carbomer in oral mucoadhesive controlled drug delivery system: review. Drug Development and Industrial Pharmacy 2000; 26(9)913–924
- Stott P., Williams A., Barry B. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. Journal of Controlled Release 1998; 50: 297–308
- Turunen T., Urtti A., Paronen P., Audus K., Rytting J. Effect of some penetration enhancers on epithelial membrane lipid domains: evidence from fluorescence spectroscopy studies. Pharmaceutical Research 1994; 11(2)288–294
- Veuillez F., Kalia Y., Jacques Y., Deshusses J., Buri P. Factors and strategies for improving buccal absorption of peptides. European Journal of Pharmaceutics and Biopharmaceutics 2001; 51: 93–109
- Xiang J., Fang X., Li X. Transbuccal delivery of 2′,3′-dideoxycytidine: in vitro permeation study and histological investigation. International Journal of Pharmaceutics 2002; 231: 57–66
- Yahagi R., Onishi H., Machida Y. Preparation and evaluation of double-phased mucoadhesive suppositories of lidocaine utilizing carbopol and white beeswax. Journal of Controlled Release 1999; 61: 1–8